Silence Therapeutics plc (SLN, SLNCF)

CIK 1479615 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Silence Therapeutics plc.

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G/A0002005369-26-000047
Aug 13, 2026SCHEDULE 13D/A0001104659-26-096202
Aug 13, 202640001104659-26-095574
Aug 12, 20268-K0001193125-26-347196
Aug 12, 2026424B50001193125-26-347191
Aug 11, 2026S-3MEF0001193125-26-345465
Aug 10, 2026424B50001193125-26-342633
Aug 10, 202610-Q0001193125-26-341248
Aug 10, 20268-K0001193125-26-341240
Aug 10, 20268-K0001193125-26-341293
Jul 16, 20268-K/A0001193125-26-306251
Jul 8, 2026SCHEDULE 13D/A0001104659-26-081559
Jul 7, 202640001104659-26-080997
Jun 23, 20268-K0001193125-26-279577
Jun 16, 20268-K0001193125-26-272814
Jun 11, 20268-K0001193125-26-266705
May 27, 2026424B50001193125-26-242060
May 27, 2026EFFECT9999999995-26-001774
May 18, 2026S-30001193125-26-228915
May 18, 20268-K0001193125-26-229089
May 7, 20268-K0001193125-26-210428
May 7, 202610-Q0001193125-26-210446
Apr 29, 2026DEF 14A0001193125-26-191786
Apr 29, 2026ARS0001193125-26-191829
Mar 5, 20268-K0001193125-26-092578